Psychedelic Mushrooms Abuse
- Table of ContentsPrint
- Psilocybin Abuse
- Signs and Symptoms
- Effects of Psilocybin Abuse
- Psilocybin Statistics
- Teen Psilocybin Abuse
Psilocybin is a psychoactive substance contained in over 100 species of mushrooms. A number of these mushroom species produce other psychoactive substances that act as hallucinogens in a similar manner to psilocybin.
“Magic mushrooms” that contain psilocybin are typically eaten or brewed as a tea 1.
Psilocybin is a substance that belongs to a class of drugs known as psychedelic drugs or hallucinogens. These drugs are typically used for the vivid perceptual effects they produce, such as hallucinations, changes in perception of time, and other sensory and perceptual effects 1.
Psilocybin use dates back many centuries. The drug is considered to be a Schedule I controlled substance without any indications for medical use by the United States Drug Enforcement Administration 2; however, there is some research to suggest that it may have potential therapeutic utility, such as for mood enhancement in patients suffering from depression 3. More research is necessary to investigate these suggested medicinal uses of psilocybin.
Signs and Symptoms
Chronic psilocybin abuse can result in an addiction, also known as other hallucinogen use disorder 4. This disorder is characterized by a problematic pattern of use causing significant impairment in the user’s life 4. The user continues to abuse magic mushrooms despite negative consequences. Common signs and symptoms of abuse include 4:
- Using more mushrooms than originally intended or for a longer period of time.
- Spending a great deal of time obtaining mushrooms, using magic mushrooms, and/or recovering from the use of mushrooms.
- Having a strong urge or desire to use mushrooms.
- Using mushrooms even when it results in a failure to fulfill personal obligations, social/interpersonal problems, or causes severe psychological or physical health issues.
- Taking mushrooms in hazardous situations, such as driving.
- Giving up activities that were once important or pleasurable to them as a result of mushroom use.
- Repeatedly failing to cut down or quit using mushrooms.
- Needing larger amounts of mushrooms to produce the desired effects.
Effects of Psilocybin Abuse
The short-term effects of psilocybin usually appear within 20 to 90 minutes of ingestion and may include 1,4:
- Visual or auditory hallucinations.
- Mixed-sensory experiences such as hearing colors or seeing sounds.
- Changes in perception of time.
- Spiritual experiences.
- Detachment from reality or self.
- Intense emotions.
- Increased respiration, temperature, and blood pressure.
- Heart palpitations.
- Increased perspiration.
- Loss of appetite.
- Dry mouth.
- Sleep disturbances.
- Blurred vision.
- Dilated pupils.
- A loss of coordination.
According to The National Institute on Drug Abuse (NIDA), the potential for magic mushrooms to produce long-term detrimental effects is not fully known and requires further research 1. When an individual is under the influence of psilocybin, their logic and reasoning abilities are compromised. In addition, some people may have negative experiences while under the influence. These unpleasant experiences are known as “bad trips” and can have lasting effects on the user.
In some cases, a user may develop hallucinogen persisting perception disorder, which occurs in about 4.2% of people who use hallucinogens 4. Those with this condition suffer from flashbacks or a re-experiencing of psilocybin intoxication despite having abstained from magic mushroom use for an extended period of time.
Individuals under the influence of psilocybin are prone to injury or death as a result of poor judgment and accidents. Magic mushroom users are also at increased risk of poisoning and potential death from accidentally ingesting a misidentified, poisonous mushroom 1.
Unlike many other drugs of abuse, long-term psilocybin use has not been shown to lead to
physical dependence or withdrawal symptoms. However, chronic users of magic mushrooms may develop tolerance, which means that they require increased doses of psilocybin in order to achieve the level of intoxication they are seeking 1. Additional research is needed to determine the addictive potential of psychedelic substances, such as psilocybin 1.
Solid and reliable statistics regarding the use of magic mushrooms are not readily available. Typically, government sources report statistics regarding the use of hallucinogenic drugs as a group. The Substance Abuse and Mental Health Services Administration (SAMHSA) reports the following statistics 6:
- In 2014, approximately 1.2 million people over the age of 12 reported being current users of hallucinogenic drugs.
- Over 500,000 adults between the ages of 18 and 25 abused hallucinogens in 2014.
- About 535,000 adults aged 26 and older were current hallucinogen users that same year.
Teen Psilocybin Abuse
Again, reliable statistics specifically relating to mushroom use are not generally recorded. The following are statistics related to teen hallucinogen use, in general 6:
- In 2014, approximately 136,000 adolescents between the ages of 12 to 17 (.5% of this population) reported being current users of hallucinogens.
- Young people with a co-occurring major depressive disorder were more likely to use hallucinogenic drugs than young people without major depression.
As mentioned above, individuals who use magic mushrooms typically eat them or brew them in a tea and may often use them in conjunction with other drugs of abuse. In order to prevent younger individuals from experimenting with psychedelic drugs like magic mushrooms, a program of education regarding the use and risks of these drugs can help to prevent abuse of the drug.
- National Institute on Drug Abuse. (2016). Drug facts: hallucinogens.
- United States Drug Enforcement Administration. (N. D.). Drug scheduling.
- Kraehenmann, R., Preller, K. H., Scheidegger, M., Pokorny, T., Bosch, O. G., Seifritz, E., & Vollenweider, F. X. (2015). Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers. Biological psychiatry, 78(8), 572-581.
- American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders – fifth edition. Washington DC: Author.
- Grob, C. S., & de Rios, M. D. (2013). Hallucinogens and related compounds. In Rosner, R. (Ed.) Clinical Handbook of Adolescent Addiction, 213-222. New York: John Wiley and Sons.
- Substance Abuse and Mental Health Services Administration. (2015). Behavioral health trends in the United States: Results from the national survey on drug use and health.